TGen President Dr. Jeffrey Trent is one of state's 'Leaders of the Year'

Arizona Capitol Times recognizes 20 Arizonans for advancing public policy

PHOENIX, Ariz. - Sept. 24, 2013 - Dr. Jeffrey Trent, President and Research Director of the non-profit Translational Genomics Research Institute (TGen), is being recognized today for his leadership in healthcare by the Arizona Capitol Times.

Dr. Trent was named by the newspaper as one of Arizona's "2013 Leaders of the Year in Public Policy" in the category of Healthcare, and will be honored at a presentation from 5:30-7:30 p.m. today, Sept. 24, at The Phoenician, 6000 E. Camelback Road, for "advancing public policy to positively impact the state and the lives of Arizonans."

"Local medical research benefits local patients first. I am honored to represent TGen faculty and staff for their extraordinary work inadvancinghealthcare, especially here in Arizona," said Dr. Trent. "Key to TGen's success is its collaboration withArizona's growing biomedical community."

Dr. Trent is being honored for his work with TGen and the advances being made across Arizona to research and find therapies for serious healthcare ailments - such as cancer, diabetes and other disorders, said Ginger Lamb, vice president and publisher of Arizona News Service and Arizona Capitol Times.

"Under Dr. Trent's leadership, TGen is on the cutting edge of research across Arizona and the country. It's hard to believe that TGen hasn't been part of Arizona for more than 11 years, given all that it has accomplished and contributed to our state. It truly is a leader in healthcare research," Lamb said.

Other honorees were selected in education, arts and humanities, business, economic development, environment, government, legislative, public safety, social services, technology, transportation, volunteerism, lifetime achievement, unsung hero, and (new this year) up and comer. Details:

# # #

About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information,

Press Contact:
Steve Yozwiak
TGen Senior Science Writer
[email protected]

Media Contact

RSS Feed